Literature DB >> 11461090

Photosensitization and mechanism of cytotoxicity induced by the use of ALA derivatives in photodynamic therapy.

A Casas1, H Fukuda, G Di Venosa, A Batlle.   

Abstract

The use of more lipophilic derivatives of 5-aminolevulinic acid (ALA) is expected to have better diffusing properties, and after conversion into the parent ALA, to reach a higher protoporphyrin IX (PPIX) formation rate, thus improving the efficacy of topical photodynamic therapy (PDT). Here we have analysed the behaviour of 3 ALA derivatives (ALA methyl-ester, hexyl ester and a 2-sided derivative) regarding PPIX formation, efficiency in photosensitizing cells and mechanism of cellular death. The maximum amount of porphyrins synthesized from 0.6 mM ALA was 47 +/- 8 ng/10(5)cells. The same amount was formed by a concentration 60-fold lower of hexyl-ALA and 2-fold higher of methyl-ALA. The 2-sided derivative failed to produce PPIX accumulation. Applying a 0.6 J cm(-2)light dose, cell viability decreased to 50%. With the 1.5 J cm(-2) light dose, less than 20% of the cells survive, and higher light doses produced nearly total cell killing. Comparing the PPIX production and the induced phototoxicity, the more the amount of porphyrins, the greater the cellular killing, and PPIX formed from either ALA or ALA-esters equally sensitize the cells to photoinactivation. ALA-PDT treated cells exhibited features of apoptosis, independently on the pro-photosensitizer employed. ALA-PDT can be improved with the use of ALA derivatives, reducing the amount of ALA necessary to induce efficient photosensitization.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11461090      PMCID: PMC2364046          DOI: 10.1054/bjoc.2001.1875

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  32 in total

1.  Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence.

Authors:  W Stummer; S Stocker; S Wagner; H Stepp; C Fritsch; C Goetz; A E Goetz; R Kiefmann; H J Reulen
Journal:  Neurosurgery       Date:  1998-03       Impact factor: 4.654

2.  Feasibility of photodynamic endometrial ablation without anesthesia.

Authors:  P Wyss; M Fehr; H Van den Bergh; U Haller
Journal:  Int J Gynaecol Obstet       Date:  1998-03       Impact factor: 3.561

3.  Clinical evaluation of a method for detecting superficial surgical transitional cell carcinoma of the bladder by light-induced fluorescence of protoporphyrin IX following the topical application of 5-aminolevulinic acid: preliminary results.

Authors:  P Jichlinski; M Forrer; J Mizeret; T Glanzmann; D Braichotte; G Wagnières; G Zimmer; L Guillou; F Schmidlin; P Graber; H van den Bergh; H J Leisinger
Journal:  Lasers Surg Med       Date:  1997       Impact factor: 4.025

4.  Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence.

Authors:  M Kriegmair; R Baumgartner; R Knüchel; H Stepp; F Hofstädter; A Hofstetter
Journal:  J Urol       Date:  1996-01       Impact factor: 7.450

5.  Derivatives of 5-aminolevulinic acid for photodynamic therapy: enzymatic conversion into protoporphyrin.

Authors:  J Kloek; W Akkermans; G M Beijersbergen van Henegouwen
Journal:  Photochem Photobiol       Date:  1998-01       Impact factor: 3.421

6.  Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid.

Authors:  L Gossner; M Stolte; R Sroka; K Rick; A May; E G Hahn; C Ell
Journal:  Gastroenterology       Date:  1998-03       Impact factor: 22.682

7.  Inhalation of 5-aminolevulinic acid: a new technique for fluorescence detection of early stage lung cancer.

Authors:  R Baumgartner; R M Huber; H Schulz; H Stepp; K Rick; F Gamarra; A Leberig; C Roth
Journal:  J Photochem Photobiol B       Date:  1996-11       Impact factor: 6.252

8.  Protease activation and cleavage of poly(ADP-ribose) polymerase: an integral part of apoptosis in response to photodynamic treatment.

Authors:  J He; C M Whitacre; L Y Xue; N A Berger; N L Oleinick
Journal:  Cancer Res       Date:  1998-03-01       Impact factor: 12.701

9.  Protoporphyrin IX accumulation in cells treated with 5-aminolevulinic acid: dependence on cell density, cell size and cell cycle.

Authors:  J Moan; O Bech; J M Gaullier; T Stokke; H B Steen; L W Ma; K Berg
Journal:  Int J Cancer       Date:  1998-01-05       Impact factor: 7.396

10.  Comparison of delta-aminolaevulinic acid and its methyl ester as an inducer of porphyrin synthesis in cultured cells.

Authors:  R Washbrook; P A Riley
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

View more
  9 in total

1.  Oleic acid as optimizer of the skin delivery of 5-aminolevulinic acid in photodynamic therapy.

Authors:  Maria Bernadete Riemma Pierre; Eduardo Ricci; Antonio Cláudio Tedesco; Maria Vitória Lopes Badra Bentley
Journal:  Pharm Res       Date:  2006-01-01       Impact factor: 4.200

2.  The effect of 5-aminolevulinic acid and its derivatives on protoporphyrin IX accumulation and apoptotic cell death in castrate-resistant prostate cancer cells.

Authors:  Ervin Teper; Peter Makhov; Konstantin Golovine; Daniel J Canter; Cynthia B Myers; Alexander Kutikov; Steven N Sterious; Robert G Uzzo; Vladimir M Kolenko
Journal:  Urology       Date:  2012-08-28       Impact factor: 2.649

3.  ALA and ALA hexyl ester in free and liposomal formulations for the photosensitisation of tumour organ cultures.

Authors:  A Casas; C Perotti; M Saccoliti; P Sacca; H Fukuda; A M del C Batlle
Journal:  Br J Cancer       Date:  2002-03-04       Impact factor: 7.640

4.  Early neoplastic and metastatic mammary tumours of transgenic mice detected by 5-aminolevulinic acid-stimulated protoporphyrin IX accumulation.

Authors:  A M Dorward; K S Fancher; T M Duffy; W G Beamer; H Walt
Journal:  Br J Cancer       Date:  2005-11-14       Impact factor: 7.640

Review 5.  Encapsulation of Gold Nanorods with Porphyrins for the Potential Treatment of Cancer and Bacterial Diseases: A Critical Review.

Authors:  Nthabeleng Hlapisi; Tshwafo E Motaung; Linda Z Linganiso; Oluwatobi S Oluwafemi; Sandile P Songca
Journal:  Bioinorg Chem Appl       Date:  2019-04-30       Impact factor: 7.778

6.  Topical application of ALA and ALA hexyl ester on a subcutaneous murine mammary adenocarcinoma: tissue distribution.

Authors:  C Perotti; A Casas; H Fukuda; P Sacca; A Batlle
Journal:  Br J Cancer       Date:  2003-02-10       Impact factor: 7.640

7.  Quantitative approach to skin field cancerization using a nanoencapsulated photodynamic therapy agent: a pilot study.

Authors:  Simone K Passos; Paulo En de Souza; Priscila Kp Soares; Danglades Rm Eid; Fernando L Primo; Antonio Cláudio Tedesco; Zulmira Gm Lacava; Paulo C Morais
Journal:  Clin Cosmet Investig Dermatol       Date:  2013-02-20

8.  ALA and ALA hexyl ester induction of porphyrins after their systemic administration to tumour bearing mice.

Authors:  C Perotti; A Casas; H Fukuda; P Sacca; A Batlle
Journal:  Br J Cancer       Date:  2002-09-23       Impact factor: 7.640

9.  Porphyrin synthesis from ALA derivatives for photodynamic therapy. In vitro and in vivo studies.

Authors:  C Perotti; H Fukuda; G DiVenosa; A J MacRobert; A Batlle; A Casas
Journal:  Br J Cancer       Date:  2004-04-19       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.